| UniProt ID | UB2D2_HUMAN | |
|---|---|---|
| UniProt AC | P62837 | |
| Protein Name | Ubiquitin-conjugating enzyme E2 D2 | |
| Gene Name | UBE2D2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 147 | |
| Subcellular Localization | ||
| Protein Description | Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination. Mediates the selective degradation of short-lived and abnormal proteins. Functions in the E6/E6-AP-induced ubiquitination of p53/TP53. Mediates ubiquitination of PEX5 and autoubiquitination of STUB1 and TRAF6. Involved in the signal-induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by DDX58/RIG-I in response to viral infection. Essential for viral activation of IRF3.. | |
| Protein Sequence | MALKRIHKELNDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDREKYNRIAREWTQKYAM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Acetylation | MALKRIHKELNDLAR CCHHHHHHHHHHHHH | 62.62 | 21791702 | |
| 8 | Ubiquitination | MALKRIHKELNDLAR CCHHHHHHHHHHHHH | 62.62 | 33845483 | |
| 74 | Phosphorylation | VAFTTRIYHPNINSN EEEEEEEECCCCCCC | 14.13 | 28152594 | |
| 80 | Phosphorylation | IYHPNINSNGSICLD EECCCCCCCCEEHHH | 38.48 | 24076635 | |
| 83 | Phosphorylation | PNINSNGSICLDILR CCCCCCCEEHHHHHH | 17.87 | 25849741 | |
| 94 | Phosphorylation | DILRSQWSPALTISK HHHHHCCCCCHHHHH | 7.83 | - | |
| 98 | Phosphorylation | SQWSPALTISKVLLS HCCCCCHHHHHHHHH | 25.88 | 21712546 | |
| 101 | Ubiquitination | SPALTISKVLLSICS CCCHHHHHHHHHHHH | 32.81 | - | |
| 105 | Phosphorylation | TISKVLLSICSLLCD HHHHHHHHHHHHHCC | 19.86 | - | |
| 115 | Ubiquitination | SLLCDPNPDDPLVPE HHHCCCCCCCCCHHH | 53.41 | 21963094 | |
| 115 | Acetylation | SLLCDPNPDDPLVPE HHHCCCCCCCCCHHH | 53.41 | 19608861 | |
| 128 | Ubiquitination | PEIARIYKTDREKYN HHHHHHHHHCHHHHH | 41.39 | - | |
| 144 | Acetylation | IAREWTQKYAM---- HHHHHHHHHCC---- | 27.83 | 21791702 | |
| 144 | Ubiquitination | IAREWTQKYAM---- HHHHHHHHHCC---- | 27.83 | 21963094 | |
| 145 | Phosphorylation | AREWTQKYAM----- HHHHHHHHCC----- | 9.70 | 20736484 | |
| 170 | Ubiquitination | ------------------------------ ------------------------------ | 21963094 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UB2D2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2D2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2D2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND MASS SPECTROMETRY. | |